Minimal deviation mucinous adenocarcinoma ('adenoma malignum') of the uterine corpus

Pathology International

Volumn 60, Issue 1, 2010, Pages 42-47

  Abiko, Kaoru ^a   Baba, Tsukasa ^a   Ogawa, Madoka ^a   Mikami, Yoshiki ^b   Koyama, Takashi ^c   Mandai, Masaki ^a   Konishi, Ikuo ^a  

^a Departments of Obstetrics and Gynecology   (North Korea)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Adenoma malignum; Minimal deviation adenocarcinoma; Mucinous; Uterine corpus

Indexed keywords

CALCIUM;

ADENOMYOSIS; ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CELL DIFFERENTIATION; CELL INFILTRATION; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MYOMETRIUM; PHENOTYPE; PRIORITY JOURNAL; VAGINA DISCHARGE;

ADENOCARCINOMA, MUCINOUS; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOPHENOTYPING; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 73649095163     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02473.x     Document Type: Article

References (27)

1. Mittal KR, Barwick KW. Diffusely infiltrating adenocarcinoma of the endometrium. A subtype with poor prognosis. Am J Surg Pathol 1988 12 : 754 758.
2. Longacre TA, Hendrickson MR. Diffusely infiltrative endometrial adenocarcinoma: An adenoma malignum pattern of myoinvasion. Am J Surg Pathol 1999 23 : 69 78.
3. Mai KT, Yazdi HM, Boone SA. 'Minimal deviation' endometrioid carcinoma with oncocytic change of the endometrium. Arch Pathol Lab Med 1995 119 : 751 754.
4. Mai KT, Perkins DG, Yazdi HM et al. Endometrioid carcinoma of the endometrium with an invasive component of minimal deviation carcinoma. Hum Pathol 2002 33 : 856 858.
5. Landry D, Mai KT, Senterman MK et al. Endometrioid adenocarcinoma of the uterus with a minimal deviation invasive pattern. Histopathology 2003 42 : 77 82.
6. Ishii K, Hosaka N, Toki T et al. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch 1998 432 : 315 322.
7. Mikami Y, Kiyokawa T, Hata S et al. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: A possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod Pathol 2004 17 : 962 972.
8. Kondo T, Hashi A, Murata S et al. Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: A report of four cases with histochemical and immunohistochemical analyses. Mod Pathol 2005 18 : 1199 1210.
9. Nara M, Hashi A, Murata S et al. Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection. Gynecol Oncol 2007 106 : 289 298.
10. Toki T, Zhai YL, Park JS et al. Infrequent occurrence of high-risk human papillomavirus and of p53 mutation in minimal deviation adenocarcinoma of the cervix. Int J Gynecol Pathol 1999 18 : 215 219.
11. Ferguson AW, Svoboda-Newman SM, Frank TS. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 1998 11 : 11 18.
12. Xu JY, Hashi A, Kondo T et al. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int J Gynecol Pathol 2005 24 : 296 302.
13. Mutter GL, Matias-Guiu X, Lax SF. Endometrial adenocarcinoma. In : Robboy SJ, Mutter GL, Prat J et al., eds. Pathology of the Female Reproductive Tract. London : Churchill Livingstone Elsevier, 2009 393 426.
14. Clement PB, Young RH. Non-endometrioid carcinomas of the uterine corpus: A review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2004 11 : 117 142.
15. Kamoi S, AlJuboury MI, Akin MR et al. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: Another viewpoint. Int J Gynecol Pathol 2002 21 : 217 223.
16. Crum CP, Duska LR, Lee KR et al. Adenocarcinoma, carcinosarcoma and other epithelial tumors of the endometrium. In : Crum CP, Lee JK, eds. Diagnostic Gynecologic and Obstetric Pathology. Philadelphia, PA : Elsevier Saunders, 2005 545 610.
17. Mazur MT, Kurman RJ. Endometrial carcinoma. In : Mazur MT, Kurman RJ, eds. Diagnosis of Endometrial Biopsies and Curettings, 2nd edn. New York : Springer, 2004 208 248.
18. Gotoh T, Hayashi N, Takeda S et al. Synchronous mucinous adenocarcinoma of the endometrium and mucinous cystadenoma of bilateral ovaries presenting during fertility therapy. Int J Gynecol Cancer 2004 14 : 169 171.
19. Yurkovetsky Z, Ta'asan S, Skates S et al. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin. Gynecol Oncol 2007 107 : 58 65.
20. Nanbu Y, Fujii S, Konishi I et al. Immunohistochemical localizations of CA 125, carcinoembryonic antigen, and CA 19-9 in normal and neoplastic glandular cells of the uterine cervix. Cancer 1988 62 : 2580 2588.
21. Fujii S, Konishi I, Nanbu Y et al. Analysis of the levels of CA125, carcinoembryonic antigen, and CA19-9 in the cervical mucus for a detection of cervical adenocarcinoma. Cancer 1988 62 : 541 547.
22. Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 1991 40 : 55 65.
23. Keys HM, Roberts JA, Brunetto VL et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 2004 92 : 744 751.
24. Susumu N, Sagae S, Udagawa Y et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008 108 : 226 233.
25. Creasman WT, Odicino F, Maisonneuve P et al. Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006 95 (Suppl. 1 S105 43.
26. Gilks CB, Young RH, Aguirre P et al. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 1989 13 : 717 729.
27. Kojima A, Mikami Y, Sudo T et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol 2007 31 : 664 672.